Company news

Bioventus Inc. news in 2022

Bioventus Inc.'s news releases, calls and decks from 2022, newest first.

View company

Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

November 20, 2022

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

November 15, 2022

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

November 7, 2022

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

October 30, 2022

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago

October 11, 2022

Bioventus to Present at the Morgan Stanley Global Healthcare Conference

August 29, 2022

Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

August 10, 2022

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite

August 2, 2022

Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

July 25, 2022

Bioventus Completes CartiHeal Acquisition

July 11, 2022

Bioventus Amends CartiHeal Acquisition Structure

June 20, 2022

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

May 9, 2022

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

May 2, 2022

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

May 1, 2022

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

April 25, 2022

Bioventus Announces $415 Million Offering of Senior Notes

April 25, 2022

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

April 24, 2022

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

April 7, 2022

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

April 4, 2022

Bioventus Exercises Call Option to Acquire CartiHeal

April 3, 2022

Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference

March 15, 2022

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

March 9, 2022

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

February 28, 2022

Bioventus Appoints Mark Singleton as Chief Financial Officer

February 27, 2022

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

February 21, 2022

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

January 10, 2022

Calls in 2022

Decks in 2022